The relationship between corticosteroids and peptic ulceration, together with the major complications of gastrointestinal haemorrhage and perforation, remains an area of clinical concern. This paper reviews the literature regarding peptic ulceration and corticosteroids. Risk factors related to an increased incidence of peptic ulceration in patients prescribed corticosteroids are discussed. These include: total dose of corticosteroid, previous history of peptic ulceration, advanced malignant disease and concurrent prescribing of nonsteroidal anti-inflammatory drugs (NSAI Ds). It is suggested that prophylaxis should be considered for those patients with two or more risk factors. Choice and efficacy of prophylaxis is also considered.
Hanks GW, Trueman T., Twycross RGCorticosteroids in terminal cancer - a prospective analysis of current practice . Postgrad Med J1983; 59: 702-706.
2.
Bruera E., Roca E., Cedaro L., Carraro S., Chacon R.Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep1985; 69: 751-54.
3.
Needham PR, Daley AG, Lennard RFSteroids in advanced cancer: survey of current practice. Br Med J1992; 305: 999.
4.
Grahame-Smith DG, Aronson JKThe Oxford textbook of clinical pharmacology and drug therapy. Oxford: Oxford University Press, 1984.
5.
MacDonald N.Principles governing the use of cancer chemotherapy in palliative medicine . In: Doyle D, Hanks GWC, MacDonald N eds. Oxford textbook of palliative medicine. Oxford: Oxford University Press, 1993: 106.
6.
Guslandi M., Tittobello A.Steroid ulcers: a myth revisited. Br Med J1992; 304: 655-56.
7.
Spiro HM, Milles SSClinical and physiologic implications of the steroid-induced peptic ulcer . N Engl J Med1960; 263: 286-94.
8.
Conn HO, Blitzer BLNonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med1976; 294: 473-79.
9.
Messer J., Reitman D., Sacks HS, Smith H., Chalmers TCAssociation of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med1983; 309: 21-24.
10.
Marshall LF , King J., Langfitt TWThe complications of high-dose corticosteroid therapy in neurosurgical patients: a prospective study. Ann Neurol1977; 1: 201-230.
11.
Dayton MT, Kleckner SC, Brown DKPeptic ulcer perforation associated with steroid use. Arch Surg1987;122:376-80.
12.
Piper JM, Ray WA, Daugherty JR, Griffin MRCorticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med1991; 114: 735-39.
13.
Schell HWAdrenal corticosteroid therapy in far-advanced cancer. Geriatrics1972; 27: 131-41.
14.
Schell HWThe risk of adrenal corticosteroid therapy in far advanced cancer. Am J Med Sci1966; 252: 641-49.
15.
Soll AH, Weinstein WM, Kurata J., McCarthy D.Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med1991; 114: 307-19.
16.
Graham DYThe relationship between nonsteroidal anti-inflammatory drug use and peptic ulcer disease. Gastroenterol Clin North Am1990; 19: 171-82.
17.
Roth SH, Bennett RENonsteroidal anti-inflammatory drug gastropathy: recognition and response . Arch Intern Med1987; 147: 2093-100.
18.
Hawkey CJNon-steroidal anti-inflammatory drugs and peptic ulcers. Br Med J1990; 300: 278-84.
19.
Griffin MR, Piper JM, Daugherty JR, Snowden M., Ray WANonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med1991; 114: 257-63.
20.
Spiro HMIs the steroid ulcer a myth?N Engl J Med1983; 309: 45-47.
21.
Twycross R.Corticosteroids in advanced cancer. Br Med J1992; 305: 969-70.
22.
Fenn GC, Robinson GCMisoprostol - a logical therapeutic approach to gastroduodenal mucosal injury induced by non-steroidal anti-inflammatory drugs? JClin Pharm Ther1991; 16: 385-409.
23.
Smith D.Omeprazole - a unique antisecretory drug. BrJ Pharm Pract1990; 12: 96-103.
24.
Fernando ONPerforated duodenal ulcer after perioperative steroid treatment. Br Med J1982; 284: 198.
25.
Tibbs PA, Rapp RP, Young B., Proudfoot G., Meeker W.Cimetidine-antacid prophylaxis for gastrointestinal bleeding in neurosurgical patients receiving steroids. Surg Forum1981 ; 32: 483-85.
26.
Ehsanullah Rsb, Page MC, Tildesley G., Wood JRPrevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. Br Med J1988; 297: 1017-21.
27.
Graham DY, Agrawal NM, Roth SHPrevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet1988; ii: 1277-80.
28.
Lanza FL, Aspinall RL, Swabb EA, Davis RE, Rack MF, Rubin A.Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology1988; 95: 289-94.
29.
Raskin J., White R., Jaszewski R.Double-blind comparative study of the efficacy and safety of misoprostol and ranitidine in the prevention of NSAID-induced gastric ulcers and upper GI symptoms: preliminary findings. Digestion1991; 49 (suppl 1): 50-51.
